Targeted therapies for kidney cancer in urologic practice.

Targeted therapies for kidney cancer in urologic practice.

Item
http://www.wikidata.org/entity/Q36934787
Prognostic impact of histological subtype on surgically treated localized renal cell carcinoma.Are all multi-targeted tyrosine kinase inhibitors created equal? An in vitro study of sunitinib and pazopanib in renal cell carcinoma cell lines.Prospective evaluation of plasma levels of ANGPT2, TuM2PK, and VEGF in patients with renal cell carcinoma.Predicting disease progression after nephrectomy for localized renal cell carcinoma: the utility of prognostic models and molecular biomarkers.Integration of surgery and systemic therapy in the management of metastatic renal cancer.Prognostic markers and targeted therapies for renal cell carcinoma.Magnetic nano-Fe3O4 particles targeted gathering and bio-effects on nude mice loading human hepatoma Bel-7402 cell lines model under external magnetic field exposure in vivo.
P2860

Targeted therapies for kidney cancer in urologic practice.

Item
http://www.wikidata.org/entity/Q36934787
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Targeted therapies for kidney cancer in urologic practice.
@en
type
label
Targeted therapies for kidney cancer in urologic practice.
@en
prefLabel
Targeted therapies for kidney cancer in urologic practice.
@en
P1433
P1476
P2093
P304
P31
P356
P433
P478
P577
P698
P356
P1433
P1476
Targeted therapies for kidney cancer in urologic practice.
@en
P2093
P304
P31
P356
10.1016/J.UROLONC.2007.05.009
P433
P478
P577
P698